A registry study on multimodality treatment for cerebral hemorrhage
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is tracking how different combination treatments affect people with cerebral hemorrhage (bleeding in the brain). It may help doctors learn which approaches work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a bleed in the brain (cerebral hemorrhage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who have had sudden, severe bleeding in the brain and received minimally invasive surgery (a less-invasive surgical approach) to treat it. Researchers want to understand outcomes and improve treatment for this serious condition.
This study tests a new disposable tube with a camera (endoscope) that doctors use to remove a blood clot from the brain after a bleeding stroke. It is designed for people who are stable enough for surgery and whose bleed is in a part of the brain that is reachable with this tool.
This trial studies how to improve care for patients who come to the emergency room with a brain bleed not caused by injury. The goal is to find better ways to manage recovery and outcomes.
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
This study is for people who had a spontaneous brain bleed and did not have surgery. It aims to learn more about their recovery and health over time.
This study looks at what happens to people after a bleed in the brain. It will help doctors understand how people recover, so they can improve care for future patients.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.